Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania
- PMID: 8649265
Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania
Abstract
Malaria, especially that due to Plasmodium falciparum, is one of the most important parasitic disease in man. It causes more than 400 million cases per year and between 1 to 3 million deaths, mainly among young children and pregnant women in sub-Saharan Africa. The current malaria control strategies using rapid diagnosis and treatment as well as methods to reduce the man-vector contact have had limited success. In Kilombero district (Southern Tanzania), malaria transmission is perennial (parasite prevalence > or = 80% all year) and intense (approximatively 300 infectious bites per year). At the household level, each under-5 child suffers on average 3 clinical fever episodes per year. Minimum estimated community rates for serious malaria (cerebral malaria or malaria and anaemia) affect approximatively 5% of all children. Under conditions of a field experiment, the annual incidence of a febrile illness (axillary temperature > or = 37.5 degrees C) reported to the curative primary health services in each child was 0.86 of which 0,35 can be attributed to Plasmodium falciparum malaria. The best estimate of the SPf66 vaccine protective efficacy in the Kilombero was 31% (95% CI : 0.52).
Similar articles
-
Efficacy trial of malaria vaccine SPf66 in Gambian infants.Lancet. 1995 Aug 19;346(8973):462-7. doi: 10.1016/s0140-6736(95)91321-1. Lancet. 1995. PMID: 7637479 Clinical Trial.
-
Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.Lancet. 1994 Oct 29;344(8931):1175-81. doi: 10.1016/s0140-6736(94)90505-3. Lancet. 1994. PMID: 7934537 Clinical Trial.
-
The development of malaria vaccines: SPf66--what next?Schweiz Med Wochenschr. 1996 Jul 9;126(27-28):1210-5. Schweiz Med Wochenschr. 1996. PMID: 8766632
-
[The investigational vaccine SPf66 against Plasmodium falciparum: myth or reality?].Sante. 1996 Jan-Feb;6(1):56-7. Sante. 1996. PMID: 8612015 Review. French. No abstract available.
-
Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.Scand J Infect Dis Suppl. 1996;102:1-53. Scand J Infect Dis Suppl. 1996. PMID: 9060051 Review.
Cited by
-
Vaccines for preventing malaria (SPf66).Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD005966. doi: 10.1002/14651858.CD005966. Cochrane Database Syst Rev. 2006. PMID: 16625647 Free PMC article. Review.
-
Measures of clinical malaria in field trials of interventions against Plasmodium falciparum.Malar J. 2007 May 2;6:53. doi: 10.1186/1475-2875-6-53. Malar J. 2007. PMID: 17475000 Free PMC article.